References
- Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Brit Med J 1969; 3: 137
- Devi B., Jennison R. F., Langley F. A. Significance of placental pathology in transplanted haemorrhage. J Clin Path 1968; 21: 322
- Fox H. White infarcts of the placenta. J Obstet Gynaec Brit Comm 1963; 70: 980
- Hedner U. Urinary fibrin(ogen) degradation products (FDP) in uraemia and after renal trasplantation. Scand J Clin Lab Invest 1973
- Hedner U., Åstedt B. Fibrinolytic split products in serum and urine in pregnancy. Acta Obstet Gynec Scand 1970; 49: 363
- Marder V. J., Shulman N. R. High molecular weight derivates of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem 1969; 244: 2111
- Melliger E. J. Detection of fibrinogen degradation products by use of antibody coated latex particles. The possibilities and limits of the method. Thrombos Diathes Haemorrh 1970; 23: 211
- Niléhn J.-E. Separation and estimation of “split products” of fibrinogen and fibrin in human serum. Thrombos Diathes Haemorrh 1967; 18: 487
- Paraskevas M., Nilsson I. M., Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Lab Invest 1962; 14: 138
- Wardle E. N., Menon I. S. Fibrinolysis in preeclamptic toxemia of pregnancy. Brit Med J 1969; 2: 625